Related Experiment Video
Updated: Sep 13, 2025

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration
Published on: May 19, 2016
FBP1 as a key regulator of focal adhesion kinase-mediated hepatic stellate cell activation: Multi-omics and
Hua-Yue Wu1, Lu Han1, Tao Ran1
1Department of Infectious Disease, The Affiliated Hospital of Guizhou Medical University, Guiyang 550004, Guizhou Province, China.
Background:
Inhibiting hepatic stellate cell (HSC) activation is a key therapeutic strategy in liver fibrosis (LF). During activation, aerobic glycolysis is upregulated to meet increased energy demands. Although focal adhesion kinase (FAK) has been implicated in regulating HSC glycolysis, its precise role in activation remains unclear.
Aim:
To investigate the effects of FAK and fructose-1, 6-bisphosphatase 1 (FBP1) on LF through the modulation of aerobic glycolysis in HSCs.
Methods:
Eighteen mice were randomly assigned to three groups: Control, carbon tetrachloride (CCl₄)-induced LF, and CCl₄ with FAK inhibitor treatment. Liver tissues were analyzed using transcriptomic and proteomic sequencing. Differential gene expression, Mfuzz clustering, and protein interaction network analyses identified key regulatory factors. Immunohistochemistry (IHC) and Western blot (WB) analysis were used to assess FAK and FBP1 expression, along with glycolysis-related enzymes. The migratory behavior of HSCs was evaluated using Transwell migration and scratch assays.
Results:
Transcriptomic and proteomic analyses revealed significantly reduced FBP1 expression in CCl₄-induced fibrosis, which was restored upon FAK inhibition. Histological staining (hematoxylin and eosin, Masson's trichrome, Sirius red) confirmed reduced fibrosis following FAK inhibition. WB analysis demonstrated suppression of glycolysis-related enzymes. In LX-2 cells, FAK inhibition attenuated HSC activation and glycolysis while upregulating FBP1. Exogenous recombinant FBP1 inhibited HSC activation and glycolysis. Transwell and scratch assays showed that FBP1 significantly impaired HSC migration. In addition, WB and IHC analyses confirmed lower FBP1 expression in fibrotic liver tissues from patients compared to healthy controls.
Conclusion:
FAK inhibitors and increased FBP1 expression inhibit aerobic glycolysis in HSCs, thereby improving LF. Thus, FAK and FBP1 may be potential targets for LF treatment.
More Related Videos
13:26Visualization and Quantification of Mesenchymal Cell Adipogenic Differentiation Potential with a Lineage Specific Marker
Published on: March 31, 2018
10:42Development of an Ethanol-induced Fibrotic Liver Model in Zebrafish to Study Progenitor Cell-mediated Hepatocyte Regeneration
Published on: May 13, 2016
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Intracellular Signaling Affects Focal Adhesions
Some...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...